Latest Insider Transactions at Longeveron Inc. (LGVN)
This section provides a real-time view of insider transactions for Longeveron Inc. (LGVN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Longeveron Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Longeveron Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2023
|
Joshua Hare Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+0.38%
|
$90,000
$3.0 P/Share
|
Sep 12
2023
|
Lisa Locklear Chief Financial Officer |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
5,000
+10.0%
|
$15,000
$3.0 P/Share
|
Sep 12
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.37%
|
$30,000
$3.0 P/Share
|
Sep 08
2023
|
Rock Soffer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.1%
|
$90,000
$3.0 P/Share
|
Sep 01
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-10.32%
|
$8,646
$2.64 P/Share
|
Aug 18
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,292
-9.29%
|
$12,876
$3.25 P/Share
|
Aug 18
2023
|
Nataliya Agafonova Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,081
-10.27%
|
$9,243
$3.36 P/Share
|
Aug 18
2023
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
767
-0.54%
|
$2,301
$3.25 P/Share
|
Jul 31
2023
|
Lisa Locklear Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
Jul 24
2023
|
Nataliya Agafonova Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
Jun 29
2023
|
James Clavijo CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
5,000
-9.56%
|
$15,000
$3.51 P/Share
|
Jun 28
2023
|
James Clavijo CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,000
-16.05%
|
$30,000
$3.43 P/Share
|
Jun 27
2023
|
James Clavijo CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
8,532
-12.04%
|
$25,596
$3.48 P/Share
|
Jun 09
2023
|
Jeffrey Pfeffer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
Jun 09
2023
|
Khoso Baluch |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
Jun 02
2023
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,999
-2.69%
|
$11,997
$3.34 P/Share
|
Jun 02
2023
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,247
-2.22%
|
$9,741
$3.25 P/Share
|
Apr 05
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,819
-7.64%
|
$7,638
$2.61 P/Share
|
Apr 03
2023
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
815
-1.08%
|
$1,630
$2.61 P/Share
|
Apr 03
2023
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
815
-0.55%
|
$1,630
$2.61 P/Share
|
Mar 01
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
Jan 27
2023
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.26%
|
$80,000
$4.28 P/Share
|
Jan 03
2023
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-1.67%
|
$3,864
$3.37 P/Share
|
Jan 03
2023
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-0.99%
|
$4,416
$3.37 P/Share
|
Dec 02
2022
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.26%
|
$60,000
$3.74 P/Share
|
Nov 16
2022
|
Joshua Hare Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,140
+0.61%
|
-
|
Oct 12
2022
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
100,000
-1.26%
|
$300,000
$3.61 P/Share
|
Oct 03
2022
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,435
-0.96%
|
$4,305
$3.75 P/Share
|
Oct 03
2022
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,256
-1.61%
|
$3,768
$3.75 P/Share
|
Jul 01
2022
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,629
-1.07%
|
$8,145
$5.94 P/Share
|
Jul 01
2022
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,426
-1.79%
|
$7,130
$5.94 P/Share
|
Jun 03
2022
|
James Clavijo CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
36,955
-31.7%
|
$295,640
$8.26 P/Share
|
Jun 03
2022
|
James Clavijo CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.55%
|
-
|
Jun 03
2022
|
Paul T Lehr General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+20.88%
|
-
|
May 24
2022
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
4,000
-0.59%
|
$28,000
$7.5 P/Share
|
May 23
2022
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
8,000
-1.17%
|
$56,000
$7.78 P/Share
|
May 20
2022
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
7,500
-1.08%
|
$60,000
$8.06 P/Share
|
May 17
2022
|
Rock Soffer |
BUY
Other acquisition or disposition
|
Direct |
500,182
+41.96%
|
-
|
May 17
2022
|
Donald M Soffer |
BUY
Other acquisition or disposition
|
Direct |
6,535,223
+49.4%
|
-
|
May 17
2022
|
Donald M Soffer |
SELL
Other acquisition or disposition
|
Indirect |
7,024,208
-100.0%
|
-
|
May 17
2022
|
Ds Med LLC |
SELL
Other acquisition or disposition
|
Direct |
7,024,208
-100.0%
|
-
|
Apr 19
2022
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
78
-0.0%
|
$780
$10.0 P/Share
|
Apr 18
2022
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,922
-0.25%
|
$199,220
$10.0 P/Share
|
Apr 13
2022
|
Donald M Soffer |
SELL
Other acquisition or disposition
|
Indirect |
748,694
-9.63%
|
-
|
Apr 13
2022
|
Rock Soffer |
BUY
Other acquisition or disposition
|
Direct |
139,912
+42.2%
|
-
|
Apr 13
2022
|
Ds Med LLC |
SELL
Other acquisition or disposition
|
Direct |
748,694
-9.63%
|
-
|
Apr 04
2022
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-1.65%
|
$19,320
$15.61 P/Share
|
Apr 04
2022
|
Geoff Green CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,840
-1.36%
|
$27,600
$15.61 P/Share
|
Apr 04
2022
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-1.3%
|
$22,080
$15.61 P/Share
|
Apr 04
2022
|
Kwan Hong Christopher Min Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
152,335
+49.81%
|
-
|